MedTech Spectrum

Article Name Clinical & Diagnostic

Seegene Unveils CURECA™ System for Fully Automated PCR Testing

Innovative platform streamlines sample-to-result diagnostics, offering scalable, multiplexed solutions for global clinical laboratories.

08th May, 2025

Aspen Neuroscience Reports Positive 6-Month Results from ASPIRO Trial for Parkinson's Cell Therapy

Personalized iPSC-derived dopaminergic neuron therapy shows early signs of safety and potential benefit in first-in-human study

08th May, 2025

Dawn Health and Merck Launch Advanced Digital Platform for Growth Disorder Management

Next-generation ecosystem enhances treatment adherence, remote monitoring, and personalized support for patients with growth hormone disorders.

07th May, 2025

SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine

Amid growing global pandemic concerns, SK bioscience partners with South Korea's national effort to advance rapid-response vaccine development against avian influenza threats.

07th May, 2025

Aptamer Group and Neuro-Bio Adapt Saliva-Based Alzheimer’s Test to ELISA Format, Advancing Towards Commercialisation

The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months.

06th May, 2025

COACH! Launches First Science-Based Fitness Platform to Redefine Musculoskeletal Recovery

Founded by leading orthopedic and physical therapy experts, COACH! bridges the gap between rehab and peak performance—empowering MSK professionals with evidence-based coaching and a nationwide network.

06th May, 2025

PureHealth Posts $137.6M Q1 Profit Under Chairman H.E. Kamal Al Maazmi and CEO Farhan Malik

Middle East's largest healthcare group posts solid growth across all segments, fueled by rising patient volumes, tech innovation, and global expansion

02nd May, 2025

Xtant Medical Unveils Trivium™ Advanced Bone Graft

Designed to optimize bone regeneration, the new graft technology promises superior clinical outcomes in spinal and orthopedic procedures.

24th April, 2025

AMDI Launches Autolab™ HBH System to Transform Sample Preparation in Under 2 Minutes

Unveiled at ESCMID Global Congress 2025, the new Hyperbaric Heating-based platform eliminates the need for extraction kits—delivering faster, simpler, and cost-effective molecular workflows across diverse research and diagnostic applications.

14th April, 2025

Modified Wellness Launches EXOMIND™ for Drug-Free Depression Treatment

Utilizing advanced TMS technology, EXOMIND™ offers a drug-free, precision-based solution for mood regulation and cognitive enhancement in clinical and wellness settings.

14th April, 2025

Hamamatsu Photonics Partners with Sirona Dx to Expand Access to Spatial Proteomics Technology

New collaboration removes adoption barriers by offering streamlined evaluation of MoxiePlex systems through a CLIA-accredited lab, combining imaging expertise with validated spatial biology support.

14th April, 2025

Cytonics Concludes Phase 1 Clinical Trial for CYT-108 in Osteoarthritis Treatment – U.S.

Milestone Marks Completion of First-in-Human Study for Innovative OA Therapy

02nd April, 2025

NUS Researchers Develop Microneedle Tech for Faster Diabetic Wound Healing

Innovative Solution Aims to Improve Recovery and Reduce Complications in Diabetes Care

27th March, 2025

Newronika’s AlphaDBS Secures CE Mark for Adaptive Deep Brain Stimulation System

Next-generation closed-loop DBS device now approved in Europe, offering real-time, personalized neuromodulation for Parkinson’s and other neurological disorders.

25th March, 2025

Immunovia’s Next-Gen Blood Test Outperforms CA19-9 in Detecting Early-Stage Pancreatic Cancer

New results from the VERIFI study show Immunovia's test accurately detects 77% of early-stage cases and maintains strong specificity across diverse high-risk groups—strengthening commercial launch plans for Q3 2025.

25th March, 2025

VolitionRx Unveils Promising Data: Nu.Q® Immunoassay Detects 21 Cancers, Eyes Multi-Licensing Deals

With low false positives and broad detection capabilities, Volition’s Nu.Q® test could reshape the $20B liquid biopsy market, as the company advances licensing talks with major diagnostic players.

24th March, 2025